We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016
A fully automated, high-throughput system for HbA1c testing will be available for inspection at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

Roche (Basel, Switzerland) will introduce the cobas c 513 analyzer at Booth 1301 of the Philadelphia expo. The c 513 is a fully automated, high-throughput HbA1c testing solution with a module that can reach a throughput of up to 400 determinations per hour. The reagent compartment has 60 reagent positions that can be loaded providing up to 14,000 results.

Image: The cobas c 513 high-throughput HbA1c analyzer (Photo courtesy of Roche).
Image: The cobas c 513 high-throughput HbA1c analyzer (Photo courtesy of Roche).

The instrument features direct results reporting, which minimizes the risk of result misinterpretation and eliminates the need for performing time-consuming, manual result interpretation. This new analyzer also offers closed tube sampling, which reduces hands-on time, prevents sample contamination, and ensures operator safety.

As the instrument is still awaiting FDA 510(k) approval, the c 513 is not currently available in the USA.

Related Links:
AACC Annual Meeting & Clinical Lab Expo
Roche

Gold Member
Turnkey Packaging Solution
HLX
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
STI Test
cobas TV/MG
New
Chikungunya Rapid Test
Chikungunya IgG/IgM Rapid Test Kit

Latest AACC 2016 News

Molecular Test Detects Three Arboviruses in Plasma Samples

Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis

New Biochip Array Developed for ApoE4 Classification